Anti-ROR1/ NTRKR1/ dJ537F10.1 monoclonal antibody
Anti-ROR1/ NTRKR1/ dJ537F10.1 antibody for FACS & in-vivo assay
Go to ROR1/ROR1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T87871-Ab-1/ GM-Tg-hg-T87871-Ab-2 | Anti-Human ROR1 monoclonal antibody | Human |
GM-Tg-rg-T87871-Ab-1/ GM-Tg-rg-T87871-Ab-2 | Anti-Rat ROR1 monoclonal antibody | Rat |
GM-Tg-mg-T87871-Ab-1/ GM-Tg-mg-T87871-Ab-2 | Anti-Mouse ROR1 monoclonal antibody | Mouse |
GM-Tg-cynog-T87871-Ab-1/ GM-Tg-cynog-T87871-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ROR1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T87871-Ab-1/ GM-Tg-felg-T87871-Ab-2 | Anti-Feline ROR1 monoclonal antibody | Feline |
GM-Tg-cang-T87871-Ab-1/ GM-Tg-cang-T87871-Ab-2 | Anti-Canine ROR1 monoclonal antibody | Canine |
GM-Tg-bovg-T87871-Ab-1/ GM-Tg-bovg-T87871-Ab-2 | Anti-Bovine ROR1 monoclonal antibody | Bovine |
GM-Tg-equg-T87871-Ab-1/ GM-Tg-equg-T87871-Ab-2 | Anti-Equine ROR1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T87871-Ab-1/ GM-Tg-hg-T87871-Ab-2; GM-Tg-rg-T87871-Ab-1/ GM-Tg-rg-T87871-Ab-2; GM-Tg-mg-T87871-Ab-1/ GM-Tg-mg-T87871-Ab-2; GM-Tg-cynog-T87871-Ab-1/ GM-Tg-cynog-T87871-Ab-2; GM-Tg-felg-T87871-Ab-1/ GM-Tg-felg-T87871-Ab-2; GM-Tg-cang-T87871-Ab-1/ GM-Tg-cang-T87871-Ab-2; GM-Tg-bovg-T87871-Ab-1/ GM-Tg-bovg-T87871-Ab-2; GM-Tg-equg-T87871-Ab-1/ GM-Tg-equg-T87871-Ab-2 |
Products Name | Anti-ROR1 monoclonal antibody |
Format | mab |
Target Name | ROR1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-ROR1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Biosimilar | GMP-Bios-ab-647 | Pre-Made Zilovertamab biosimilar, Whle mAb, Anti-ROR1 Antibody: Anti-NTRKR1/dJ537F10.1 therapeutic antibody |
Biosimilar | GMP-Bios-INN-1057 | Pre-Made Zilovertamab Vedotin Biosimilar, Whole Mab Adc, Anti-Ror1 Antibody: Anti-NTRKR1/dJ537F10.1 therapeutic antibody Drug Conjugate |
Target Antigen | Products Developing | Multi-species ROR1/ NTRKR1/ dJ537F10.1 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | vGMLV000229 | human ROR1 Lentivirus particle |
ORF Viral Vector | pGMAD000585 | human ROR1 Adenovirus plasmid |
ORF Viral Vector | vGMAD000585 | human ROR1 Adenovirus particle |
ORF Viral Vector | pGMLV000229 | human ROR1 Lentivirus plasmid |
Target information
Target ID | GM-T87871 |
Target Name | ROR1 |
Gene ID | 4919,26563,362550,700760,489557,101100987,783965,100069962 |
Gene Symbol and Synonyms | 2810404D04Rik,dJ537F10.1,NTRKR1,RGD1559469,ROR1 |
Uniprot Accession | Q01973 |
Uniprot Entry Name | ROR1_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Immuno-oncology Target, INN Index |
Disease | N/A |
Gene Ensembl | ENSG00000185483 |
Target Classification | Checkpoint-Immuno Oncology |
The target: ROR1, gene name: ROR1, also named as NTRKR1, dJ537F10.1. This gene encodes a receptor tyrosine kinase-like orphan receptor that modulates neurite growth in the central nervous system. The encoded protein is a glycosylated type I membrane protein that belongs to the ROR subfamily of cell surface receptors. It is a pseudokinase that lacks catalytic activity and may interact with the non-canonical Wnt signalling pathway. This gene is highly expressed during early embryonic development but expressed at very low levels in adult tissues. Increased expression of this gene is associated with B-cell chronic lymphocytic leukaemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2012].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.